KE Bollinger, SD Smith - Current Opinion in Ophthalmology, 2009 - journals.lww.com Purpose of review: The fluocinolone acetonide intravitreal implant was approved
by the United States Food and Drug Administration in April, 2005 for treatment
of noninfectious posterior segment uveitis (NIPU). This therapy is ... Cited by 1 - Related articles - All 2 versions
A Sallam, HG Sheth, Z Habot-Wilner, S … - American Journal of Ophthalmology, 2009 - Elsevier Of 891 patients with uveitis, 191 (275 eyes) had IOP elevation (21.4%). Of
these, 95 (34.5%) eyes had glaucoma. IOP elevation attributed to
corticosteroid-response (61.1%) was controlled more easily than that ... Related articles - All 14 versions
- ►mcg.edu [PDF] … , A Kostakou, I Halkiadakis, S Chalkidou, D … - Graefe's Archive for Clinical and Experimental …, 2009 - Springer Abstract Background To compare the efficacy and safety of latano- prost against
a fixed combination of dorzolamide and timolol in eyes with elevated intraocular
pressure (IOP) or glaucoma and anterior or intermediate uveitis. Methods ... Related articles - All 3 versions
JL Alió, B Bodaghi, MJ Tassignon - Ophthalmology Times, 2008 - oteurope.com Since cataract surgery was first described, inflammation has always been
accepted as a natural consequence of the procedure. Yet, despite the years of
experience surgeons have had with this natural side effect, a clear ... Related articles - View as HTML